U.S. Federal Judge Rejects Flavored Vape Maker’s Appeal, Upholds New York City Enforcement

Jul.16.2025
U.S. Federal Judge Rejects Flavored Vape Maker’s Appeal, Upholds New York City Enforcement
On July 15, 2025, a Manhattan federal judge denied a motion to dismiss New York City’s lawsuit against eight e-cigarette wholesalers accused of illegally selling flavored vapes. The court affirmed the city’s right to sue and upheld its claims.

Key points:

 

·A federal judge in Manhattan has denied a motion to dismiss by eight e-cigarette wholesalers. 

 

·New York City has accused the defendants of violating federal, state, and local laws by illegally selling flavored e-cigarettes. 

 

·The court found the city's lawsuit to be valid and rejected the defendants' motion.

 


【2Firsts News Flash】According to a report from Law360 on July 15th, the city of New York has filed a lawsuit against companies selling flavored e-cigarettes, alleging that these companies have violated federal, state, and local laws by selling large quantities of flavored e-cigarettes in the city. On July 15, 2025, Manhattan federal judge Gregory H. Woods denied a request from eight e-cigarette wholesalers to dismiss the lawsuit.

 

In a 33-page ruling, Judge Woods determined that New York City officials exercised their authority when initiating law enforcement actions, and the city has justifiably claimed that multiple defendants were illegally selling e-cigarette products.

 

"The motion to dismiss by the defendants was rejected because the city claimed that each defendant who had their application dismissed had sent e-cigarettes to unlicensed buyers in New York State and sold flavored e-cigarettes in New York City, violating local ordinances."

 

The judgment stated.

 

The city of New York initially filed a lawsuit against these e-cigarette retailers in New York state court in April 2024. Two months later, the lawsuit was moved to federal court, and in August 2024, the city of New York filed its amended complaint in federal court.

 

New York City alleges that these e-cigarette retailers violated the citywide ban on flavored e-cigarettes, New York state laws prohibiting businesses from shipping e-cigarettes to stores without state permits, and the federal Prevent All Cigarette Trafficking (PACT) Act by remotely selling to unlicensed stores.

 

"The defendants named in this case have almost certainly violated every federal, state, and city law designed to regulate the marketing, distribution, and sale of flavored e-cigarettes."

 

New York City stated in its second amended complaint.

 

The city of New York further asserts that these businesses constitute a public nuisance under New York common law, a claim which the court found credible in its ruling on July 14th.

 

"The city has reasonably argued for public nuisance because it claims to have enough evidence to show that the defendants being sued supplied flavored e-cigarettes in New York City, exacerbating a public health crisis."

 

The ruling stated.

 

The parties whose applications were rejected include 8 out of the 12 defendants, who generally claim that New York City lacks the authority to enforce state and federal laws, and that the city has failed to reasonably assert that the defendants have violated any state or local laws.

 

The court found that these claims lack basis. Specifically, Judge Woods wrote that New York City has the right to sue under the PACT Act because it imposes excise and sales taxes on nicotine products, and just because the defendants hold operating permits does not mean that their illegal sales cannot be restricted through city enforcement actions.

 

"The defendants whose application was denied do not deny that there are addictive flavored e-cigarettes all over New York City, which poses a threat to public health. Instead, the defendants whose application was denied argue that the city has failed to reasonably claim that they have sold these products to businesses and individuals in New York, a claim that has been rejected by the court."

 

The court stated.

 

As of July 15, the defendant and representatives from the city of New York have not yet responded to requests for comments.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FRE Nicotine Pouches Partners with Taylor Reimer Racing, Covering Four 2026 ARCA Events
FRE Nicotine Pouches Partners with Taylor Reimer Racing, Covering Four 2026 ARCA Events
FRE® Nicotine Pouches announced a partnership with Taylor Reimer Racing, becoming the Official Nicotine Sponsor for four races in the 2026 ARCA Menards Series and serving as the primary sponsor at events in Alabama, Michigan, Minnesota, and Arizona. FRE branding will appear on the race car, driver suit, and helmet, and the collaboration will also extend to off-track content and activations.
Feb.27
Exclusive: Glas says FDA-authorized G2 vape includes age-gating technology
Exclusive: Glas says FDA-authorized G2 vape includes age-gating technology
Glas has confirmed to 2Firsts that its G2 device, which received a FDA Marketing Granted Order (MGO), incorporates age-gating technology. Based on currently public information, this means the FDA has granted an MGO to the first ENDS product confirmed to incorporate age-gating technology, validating 2Firsts’ earlier inference.
Mar.17
Bonnie Herzog:U.S. nicotine market seen at about $67B in revenue by 2035 as smoke-free expands
Bonnie Herzog:U.S. nicotine market seen at about $67B in revenue by 2035 as smoke-free expands
Goldman Sachs Managing Director Bonnie Herzog said the U.S. nicotine market is attractive and growing, with total revenue projected to reach about $67 billion by 2035. She expects cigarettes to account for a smaller share of revenue (47%) as smoke-free revenue expands and becomes a key driver of industry profit growth. Herzog said smoke-free products represent about 48% of U.S. nicotine volumes today and could rise to roughly 75% by 2035.
Mar.04 by 2FIRSTS.ai
Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension
Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension
A cross-sectional analysis based on the US NHANES 2021–2023 cycle, including 6,262 participants aged over 12, found that compared with people who neither smoke nor vape, those who smoke and/or use e-cigarettes had a higher prevalence of elevated blood pressure and hypertension. After full adjustment, smoking/vaping was associated with elevated blood pressure (aOR 1.34) and hypertension (aOR 1.46), and with a 1.05 mmHg higher diastolic blood pressure.
Feb.09 by 2FIRSTS.ai
2Firsts Interview with Glas |Why a California ENDS Company Believes Its Age-gated Flavored Vape Could Be Next in Line for FDA Authorization
2Firsts Interview with Glas |Why a California ENDS Company Believes Its Age-gated Flavored Vape Could Be Next in Line for FDA Authorization
As the FDA advances efforts to streamline its PMTA review process, including support for small businesses, expectations are rising that additional product authorizations may follow. Age-verification technology is emerging as a key consideration in future approvals.In this interview, California-based Glas discusses its G2 platform, integrating smartphone-based identity verification, proximity controls and anti-counterfeit systems, and outlines its positioning under the FDA’s PMTA framework.
Mar.02
Singapore to Extend Etomidate Controls and Table New Vape Legislation in 2026
Singapore to Extend Etomidate Controls and Table New Vape Legislation in 2026
Singapore will maintain etomidate’s classification under drug control laws while preparing new legislation targeting e-vaporisers, as authorities reinforce a hardline regulatory stance on vaping.
Feb.05